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Background: Disability and chronic conditions both have an impact on health expenditures and although they are
conceptually related, they present different dimensions of ill-health. Recent concepts of disability combine a
biological understanding of impairment with the social dimension of activity limitation and resulted in the
development of the Global Activity Limitation Indicator (GALI). This paper reports on the predictive value of
the GALI on health care expenditures in relation to the presence of chronic conditions.
Methods: Data from the Belgian Health Interview Survey 2008 were linked with data from the compulsory
national health insurance (n = 7,286). The effect of activity limitation on health care expenditures was
assessed via cost ratios from multivariate linear regression models. To study the factors contributing to the
difference in health expenditure between persons with and without activity limitations, the Blinder-Oaxaca
decomposition method was used.
Results: Activity limitations are a strong determinant of health care expenditures. People with severe
activity limitations (5.1%) accounted for 16.9% of the total health expenditure, whereas those without
activity limitations (79.0%), were responsible for 51.5% of the total health expenditure. These observed
differences in health care expenditures can to some extent be explained by chronic conditions, but activity
limitations also contribute substantially to higher health care expenditures in the absence of chronic
conditions (cost ratio 2.46; 95% CI 1.74-3.48 for moderate and 4.45; 95% CI 2.47-8.02 for severe activity
limitations). The association between activity limitation and health care expenditures is stronger for
reimbursed health care costs than for out-of-pocket payments.
Conclusion: In the absence of chronic conditions, activity limitations appear to be an important
determinant of health care expenditures. To make projections on health care expenditures, routine data on
activity limitations are essential and complementary to data on chronic conditions.
Keywords: Activity limitations, Disability, Health care expenditures, Chronic conditionsBackground
Health care expenditures represent an increasing part of
the GDP in all OECD countries. In Belgium the propor-
tion of the GDP devoted to health care rose from 8.1%
to 10.5% between 2000 and 2011 [1]. There is no doubt
that - apart from the development of new technologies* Correspondence: johan.vanderheyden@wiv-isp.be
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article, unless otherwise stated.and drugs - population ageing and the associated higher
burden of ill-health have contributed to this trend.
When assessing the burden of ill-health at the popula-
tion level, many studies highlight the role of disability.
Several frameworks exist to conceptualise disability [2,3].
Recent disability measures target functioning ability rather
than impairment. Examples of measures include the
Washington Group General Disability Measure [4],
activities of daily living (ADLs) [5] and instrumental activ-
ities of daily living (IADLs) [6]. These standard instru-
ments tap basic and intermediate levels of functioning,d Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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domains. However, the way in which functional limitations
lead to activity limitations (i.e. have an impact on partici-
pation to society) also depends on external factors. This is
clearly reflected in the definition of the International Clas-
sification of Functioning, Disability, and Health (ICF), in
which disability is defined as a difficulty in functioning at
the body, person, or societal levels, in one or more life
domains, as experienced by an individual with a health
condition in interaction with contextual factors [7].
This definition combines a biological understanding of
impairment with the social dimension of activity re-
strictions [8].
The need for a global disability indicator that would
capture higher-order level of functioning [9] resulted in
the development of the Global Activity Limitation Indi-
cator (GALI). The GALI identifies subjects with long-
standing (at least 6 months) limitations due to a health
problem by severity level via a single question [10]. The
indicator refers to general restrictions in activity without
specifying the type of activity (work, household chores,
leisure, personal care etc.). Activity limitations due to
non-health related problems are not included. The se-
verity level relates to the activity limitations, not to the
seriousness of the health problem. The GALI has been
designed as a comprehensive health measure, underlying
the EU indicator Healthy Life Years [11] and is used par-
ticularly for health expectancy comparisons across Europe,
especially the monitoring of the progress towards the glo-
bal target of two additional healthy life years (HLY) at
birth by 2020 in the EU on average [12]. It is included in
the European Survey on Income and Living Conditions
(EU-SILC), the European Health Interview Survey (EHIS)
and the Survey of Health, Ageing and Retirement in Europe
(SHARE) and is therefore one of the indicators for which
sustainable and comparable information is sought across all
EU countries. The GALI has been validated in Belgium and
other EU countries [13-18]. Both in the general population
and in older people, activity limitations measured via the
GALI appear to be an important predictor of short term
mortality [19].
Disability is often related with the presence of chronic
conditions, which include essentially physical and mental
diseases, and also risk factors such as hypertension and
hyperlipidaemia are chronic conditions [20]. Although
the terms “chronic conditions” and “disability” are some-
times mixed up, current views prefer to consider them
as related, but separate concepts [21]. People with
chronic conditions may experience some form of disabil-
ity, but not every person with a disability experiences a
chronic health problem. Therefore in public health re-
search, a distinction should be made between a) individ-
uals with disabilities without any chronic condition b)
individuals with disabilities who also have unrelatedchronic conditions, and c) individuals with disabilities
who developed a disability as a results of chronic condi-
tions [22]. Disentangling the impact of disability and
chronic conditions on health care expenditures will in-
crease our knowledge on the need factors that lead to
health care expenditures and provide evidence to health
policy makers on the usefulness of routine data collec-
tion on both chronic diseases and disability for planning
purposes.
To date, no studies have looked at the relation be-
tween disability and health care expenditures by making
use of the GALI. Moreover, although some studies inves-
tigated the link between disability and health care expen-
ditures, most of them were done in the US, focused on
either health insurance expenses or out-of-pocket ex-
penses and did not take into account at the same time
the presence of chronic diseases and disability [23-27].
The Belgian health system is quite different from the
one in the US. It is characterised by therapeutic freedom
for physicians, freedom of choice for patients, a compul-
sory health insurance, and remuneration based on both
fee-for-service payments and direct payments via sick-
ness funds [28]. This study investigated the relation be-
tween activity limitations on health care expenditures in
Belgium in relation to chronic conditions. This was
assessed for the total health expenses, and for reim-
bursed and out-of-pocket expenses separately. Further-
more it was assessed to which extent differences in
health care expenditures by activity limitation can be ex-
plained or differ by socio-demographic characteristics
and prevalence of chronic conditions.
Methods
Data
Data used in the study were from the Belgian National
Health Interview Survey (HIS) 2008, which was con-
ducted between May 2008 and July 2009 among a repre-
sentative sample of Belgian residents (N = 11,253). A
detailed description of the design and sampling methods
can be found elsewhere [29]. The HIS data were linked
to the health insurance register to obtain health care ex-
penditures of all participants. The survey was carried
out by Statistics Belgium and exempted by law from
requiring ethics approval. For the use of the survey
data and the linkage to the health insurance data,
authorization was obtained from the Belgian Commission
for the Protection of Privacy. Health insurance is compul-
sory in Belgium and covers more than 99% of the popula-
tion. Individual linkage between the HIS and health
insurance data was performed using a unique identifier.
Analyses had to be restricted to 7,286 respondents aged
15 years and older for whom linkage was possible with the
health insurance register, who had answered the GALI-
question in the self-administered questionnaire (which
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and for whom health expenditure data were available for a
period of 12 months following participation to the survey
(Figure 1).
Health care expenditures were obtained for the years
2008, 2009 and 2010. A distinction was made between
health care expenditures for (1) ambulatory care (exclud-
ing the cost of pharmaceuticals), (2) hospital care and
(3) reimbursed medicines obtained in pharmacies. For a
small group of expenses, this information was not avail-
able. The database included information on health ex-
penses covered by the health insurance, out-of-pocket
expenses, and supplemental payments. Supplemental
payments are additional health expenses for patients
who opt for extra services, e.g. a hospital bed in a private
room. In Belgium, hospitals also get a fixed amount per
admitted patient from the health insurance. Information
on this fixed part was not available in the database.
Activity limitations were measured with the GALI.
The initial version of the question was used: “For the
past 6 months or more have you been limited in activ-
ities people usually do because of a health problem?People below 15 years (N = 1603
did not belong to study populatio
No linkage with health insurance reg
possible for 424 individuals
No self-administered questionnaire (bec
proxy interview  or other reason) for 1794 
No valid answer to GALI
for 113 individua
33 individuals died in the 
following participation in t
(Tot
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formation was available on the one-year prevalence of
30 specific chronic conditions and health problems.
Chronic conditions were included in the multivariate
model if there appeared to be an independent associ-
ation with health expenditure after adjustment for age,
gender and the other chronic conditions.
A composite indicator on chronic conditions was cre-
ated distinguishing persons with none of the identified
chronic conditions, one condition and two or more con-
ditions. Further information used in the analyses in-
cluded age, gender, educational attainment, income level,
household type, nationality and degree of urbanization.
Educational attainment was defined at the household
level and based on the highest diploma obtained by the
reference person or the partner, if any. Four categories
were considered: no diploma or only primary education,
lower secondary, higher secondary and tertiary education.
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income were calculated [30]. Five household types where
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regrouped into Belgian, non-Belgian from an EU country
and non-Belgian from outside the EU. The degree of ur-
banisation was based on morphological and functional
characteristics of municipalities, derived from census data,
which resulted into an indicator with three categories:
urban, semi-urban and rural municipalities [31,32].
Analyses
Descriptive results on overall health expenses, and
health expenses by type and reimbursement modalities,
were presented in function of the prevalence of activity
limitations. Multivariate linear regression models were
used to explore the association of health expenses with
activity limitations in relation to chronic conditions and
potential socio-demographic determinants. To account
for the skewedness of the health care costs, the natural
logarithm was used as dependent variable. One euro was
added to all costs to enable a logarithmic transformation
for people who had not incurred any health costs. Vari-
ability in health care expenditures was expressed as cost
ratios (CR) of the logarithm of the expenses compared
to a reference category [33,34].
To study the factors contributing to the difference in
health expenditure between persons with and without
activity limitations, the Blinder-Oaxaca decomposition
method was used [35-37]. Although multivariate regression
models are suitable to address differences in the import-
ance of individual factors, the Blinder-Oaxaca technique
demonstrates the relative importance of each predictor.
The decomposition illustrates the fraction of the gap in
health care expenditures that is attributable to group differ-
ences in the magnitude of the determinants (the explained
or prevalence component) and to group differences in the
effects of these determinants (the unexplained or impact
component). The Blinder-Oaxaca decomposition method
is particularly useful to study differences in health care ex-
penditures between two groups [38,39], but it has also been
used in studies in which the contribution of both the
prevalence and the impact of determinants to explain dif-
ferences between groups was investigated for other health
outcomes [40,41]. Further information on the Blinder-
Oaxaca decomposition is presented in an Additional file 1.
The sampling design of the Belgian HIS 2008 included
stratification, clustering and over representation of the
population aged 75 years and older and residents living
in the Brussels-Capital Region. Analyses were done with
Stata 13 [42] taking into account the design settings of
the survey.
Results
Within the study population aged 15 years and older,
5,461 individuals (79.0%) had no activity limitations,
1,364 (14.9%) reported moderate activity limitations and461 (5.1%) severe activity limitations. Table 1 presents
socio-demographic characteristics and chronic disease
status of the study participants for the total sample and
by level of activity limitations. It shows that chronic dis-
eases and activity limitations are strongly related. Yet,
among people with severe activity limitations, 12.8% had
no chronic condition.
People with severe activity limitations accounted for
16.9% of the total health expenditure, whereas those
without activity limitations were responsible for 51.5% of
the total health expenditure. On average 57.0% of the
expenses were ambulatory costs, 21.8% hospital costs
(excluding fixed costs, as explained in the methods sec-
tion), 18.2% costs for reimbursed medicines obtained in
pharmacies and 3.0% not specified. The large majority
of expenses (84.0%) were covered by the health insur-
ance, 10.9% were out-of-pocket payments and 5.1%
supplements.
Table 2 shows descriptive results of the mean health
care expenditures in the 12 months following the partici-
pation of the survey. Overall average yearly health care
expenditures increased from 1,220 euro per year among
people with no limitation, over 3,803 euro among people
with moderate limitations to 7,358 euro among people
with limitations.
Although the mean values are highly influenced by the
individuals with high expenditures, the median values
also differ substantially by level of activity limitations:
for people with no limitation the median was 506 euro;
for people with moderate and severe limitations median
expenditures were 1,965 euro and 3,768 euro, respect-
ively. The contribution of reimbursed health care expen-
ditures increased with the severity of limitations: from
81.8% if no limitations are reported to 86.3% in case of
moderate and 89.9% in case of severe limitations. The
differences are significant (p < 0.001) after adjustment
for age and gender.
Fifteen out of 30 chronic conditions were significantly
associated with higher health care expenditures after ad-
justment for age, gender and the other chronic condi-
tions (Table 3).
The association was highest for cancer (CR 3.77), kid-
ney problems other than kidney stones (CR 2.73) and
diabetes (CR 2.31), and was also significant, in descend-
ing order of the magnitude of the association, for coron-
ary heart disease (CR 1.92), myocardial infarction (CR
1.90), depression (CR 1.78), peptic ulcer (CR 1.62),
hypertension (CR 1.50), asthma (CR 1.44), problems of
the large bowel (CR 1.43), stroke (CR 1.36), chronic
bronchitis (CR 1.33), thyroid problems (CR 1.30), neck
disorder (CR 1.22) and osteoarthritis (CR 1.19).
Table 4 presents differences in health expenditure by
level of activity limitation and by number of chronic
conditions after adjustment for age, gender, education,
Table 1 Socio-demographic characteristics and chronic disease status of study participants by level of activity
limitation (AL)
Total No AL Moderate AL Severe AL
%§ N %§ N %§ N %§ N
Gender
Men 47.9 3,353 49.8 2,638 41.4 552 38.2 163
Women 52.1 3,933 50.2 2,823 58.6 812 61.8 298
Age (in years)
15-24 13.1 869 15.9 828 2.9 31 2.2 10
25-44 33.5 2,238 37.9 1,973 17.3 205 14.7 60
45-64 33.7 2,260 31.9 1,674 41.1 453 38.2 133
65+ 19.8 1,919 14.3 986 38.7 675 44.9 258
Education
No diploma/only primary 10.4 904 7.8 489 19.2 282 25.0 133
Lower secondary 15.4 1,161 13.5 756 22.6 285 23.8 120
Higher secondary 33.3 2,260 33.9 1,744 31.5 402 29.8 114
Tertiary 40.8 2,797 44.9 2,360 26.8 357 21.5 80
Income
Quintile 1 17.5 1,192 16.3 820 21.9 277 22.0 95
Quintile 2 17.8 1,231 15.3 786 23.4 307 36.5 138
Quintile 3 19.3 1,144 18.5 826 22.0 232 22.4 86
Quintile 4 21.8 1,223 23.5 992 17.4 182 10.8 49
Quintile 5 23.7 1,427 26.4 1,203 15.3 188 8.4 36
Nationality
Belgian 92.5 6,513 91.9 4,827 94.2 1,255 95.5 431
Non-Belgian EU 5.3 542 5.6 440 4.3 79 3.4 23
Non-Belgian non-EU 2.3 211 2.5 178 1.5 27 1.1 6
Household type
Single 18.0 1,922 15.2 1,220 26.6 494 33.8 208
One parent with child(ren) 7.6 580 7.9 463 7.0 84 5.7 33
Couple with child(ren) 26.7 1,859 24.1 1,274 36.7 445 37.4 140
Couple without child(ren) 37.1 2,248 42.0 1,985 19.4 211 15.2 52
Other or unknown 10.6 677 10.9 519 10.3 130 7.9 28
Degree of urbanisation
Urban 45.9 3,946 44.7 2,911 49.3 777 53.5 258
Semi-urban 23.1 1,292 23.3 966 23.1 244 20.1 82
Rural 31.0 2,048 32.0 1,584 27.5 343 26.4 121
Chronic disease status
No chronic condition# 56.5 3,695 66.4 3,380 21.5 256 12.8 59
1 chronic condition# 22.7 1,632 21.4 1,167 28.5 362 24.6 103
≥2 chronic conditions# 20.8 1,710 12.3 728 50.0 697 62.6 285
§Weighted percentage.
#The following chronic conditions are considered: asthma, chronic bronchitis, myocardial infarction, coronary heart disease, stroke, hypertension, osteoarthritis,
neck disorder, depression, peptic ulcer, problem large bowel, diabetes, thyroid problems, kidney problems except for kidney stones, cancer.
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Table 2 Mean annual health expenses (in euro) in function of activity limitation
Not limited
(n = 5,461)
Moderately limited
(n = 1,364) Severely limited (n = 461) All (n = 7,286)
Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI)
By type of health expenses
Ambulatory care (no medicines) 713 (662-764) 2,143 (1,869-2,417) 3,989 (3,342-4,636) 1,108 (1,034-1,181)
Hospital care 257 (189-326) 784 (627-941) 1,748 (1,221-2,275) 417 (351-484)
Reimbursed medicines obtained in pharmacies 220 (201-239) 770 (668-872) 1,370 (1,042-1,699) 366 (336-396)
Not specified 32 (27- 37) 116 (96-137) 280 (192-369) 58 (51-65)
By payment modality
Health insurance 998 (898-1,098) 3,283 (2,941-3,624) 6,614 (5,658-7,570) 1,648 (1,530-1,766)
Out-of-pocket 158 (149-167) 374 (346-402) 567 (476-658) 213 (203-224)
Supplement 64 (55-74) 147 (108-185) 178 (103-254) 83 (73-94)
All health expenses 1,220 (1,110-1,329) 3,803 (3,435-4,170) 7,358 (6,309-8,408) 1,944 (1,815-2,073)
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banisation. Both activity limitations and chronic condi-
tions contribute independently to health expenditure.
The adjusted CR was 1.88 and 3.21 in people with re-
spectively moderate and severe limitations. People with
one chronic condition (among the 15 that were se-
lected) had an adjusted cost ratio of 1.82 compared to
those without any of those diseases; for those with
more than one chronic conditions the CR was 2.84.
Chronic conditions and activity limitations contributed
in a cumulative way to increase health care expendi-
tures. In the absence of an activity limitation, the ad-
justed CR for those with one chronic condition was
1.94 and for those with two or more chronic conditions
3.01. Among persons with no chronic condition, the
adjusted CR was 2.46 if they had a moderate activity
limitation and 4.45 in case of a severe activity limita-
tion. However, a severe activity limitation in combin-
ation with more than one chronic condition yielded an
adjusted CR of 9.60. The interaction between activity
limitation and chronic condition was not significant
(results not shown), which indicates that the associ-
ation between activity limitation and health care ex-
penditure did not depend on the presence of a chronic
condition.
This was confirmed in a stratified analysis, separating
respondents with no, one and two or more chronic condi-
tions. In the group with no chronic conditions, the adjusted
CR of health expenses was 2.47 for people with moderate
activity limitations and 4.21 for people with severe activity
limitations. Also in the two groups with chronic diseases
there was a clear association between health expenses and
activity limitations.
It is striking that differences in cost ratios are far more
pronounced for payments covered by the health insur-
ance than for out-of-pocket expenses and supplements.
The adjusted CR for people with a severe activitylimitation and more than one chronic condition com-
pared to those with none of both is much higher (10.22)
for payments covered by the health insurance, than for
out-of-pocket payments (5.31) and supplements (4.11).
The decomposition analysis (Table 5) shows that
47.9% (0.768/1.605; p < .001) of the difference in health
care expenditures between people with and without
activity limitations can be explained by variation in
the distribution of socio-demographic characteristics
and prevalence of chronic conditions, meaning that al-
most half of the gap in health care expenditures would
be mitigated if people with activity limitations would
have the same characteristics as people without activ-
ity limitations. The difference in impact of those char-
acteristics, which corresponds to the unexplained gap
(meaning the change in health care expenditures
among people with activity limitations when applying
coefficients of people without activity limitations to
those with activity limitations) accounts for 52.1%
(0.837/1.605; p < 0.001) of the gap in health care ex-
penditures. Age, gender and education influence sig-
nificantly the gap via both the prevalence and the
impact. Differences in the prevalence of chronic con-
ditions between people with and without activity limi-
tations explain 22.2% (0.356/1.605; p < 0.001) of the
gap in health care expenditures, but the impact of
chronic conditions on people with activity limitations
does not yield significantly different health care ex-
penditures than in people without activity limitations
(p = 0.260).
The decomposition analysis reveals more or less simi-
lar results for health care expenditures covered by the
health insurance, out-of-pocket payments and supple-
ments. Nevertheless, the fraction of the gap in health
care expenditures between people with and without ac-
tivity limitations that can be explained by differences in
socio-demographic characteristics and prevalence of
Table 3 Prevalence of chronic conditions considered in the study and cost ratio (CR) of total health expenses for
persons with the disease compared to those without
Prevalence (weighted %) (95% CI) CR§(95% CI)
Respiratory problems
Asthma 4.1 (3.6-4.8) 1.44* (1.15-1.81)
Chronic bronchitis 3.9 (3.4-4.5) 1.33* (1.06-1.68)
Cardiovascular problems
Myocardial infarction 0.7 (0.5-0.9) 1.90* (1.28-2.84)
Coronary heart disease 2.1 (1.7-2.6) 1.92* (1.33-2.78)
Stroke 1.0 (0.7-1.3) 1.36* (1.01-1.82)
Hypertension 15.9 (14.7-17.1) 1.50* (1.30-1.73)
Musculoskeletal problems
Rheumatoid arthritis 7.2 (6.5-8.0) 1.12 (0.92-1.37)
Osteoarthritis 16.0 (14.8-17.2) 1.19* (1.00-1.40)
Low back disorder 21.1 (19.7-22.4) 1.08 (0.91-1.27)
Neck disorder 11.9 (10.9-12.9) 1.22* (1.03-1.44)
Osteoporosis 4.6 (4.1-5.3) 0.83 (0.64-1.07)
Neurological problems
Headache/migraine 10.0 (9.1-11.9) 1.15 (0.95-1.39)
Parkinson’s disease 0.4 (0.2-0.6) 2.00 (0.60-6.71)
Epilepsy 0.6 (0.4-1.0) 1.69 (0.88-3.22)
Psychological problems
Chronic anxiety 5.2 (4.6-6.0) 1.23 (0.99-1.53)
Depression 6.0 (5.3-6.8) 1.78* (1.44-2.20)
Problems related to digestive system
Peptic ulcer 3.7 (3.1-4.4) 1.62* (1.22-2.15)
Liver problems 0.5 (0.4-0.7) 1.61 (0.76-3.39)
Problems of the large bowel 3.2 (2.7-3.8) 1.43* (1.10-1.88)
Gall-bladder problems 0.7 (0.5-0.9) 0.96 (0.58-1.62)
Problems related to endocrine system
Diabetes 3.8 (3.3-4.4) 2.31* (1.91-2.79)
Thyroid problems 4.5 (4.0-5.2) 1.30* (1.04-1.62)
Urinary problems
Urinary incontinence 3.3 (2.8-3.9) 1.24 (0.93-1.65)
Chronic cystitis 1.3 (1.0-1.6) 1.13 (0.83-1.54)
Kidney stones 0.7 (0.5-1.0) 0.88 (0.37-2.10)
Other kidney problems 0.7 (0.5-0.9) 2.73* (1.22-6.09)
Eye problems
Glaucoma 1.7 (1.4-2.1) 1.17 (0.86-1.58)
Cataract 2.8 (2.4-3.3) 1.00 (0.78-1.28)
Other problems or diseases
Cancer (all types) 2.1 (1.7-2.6) 3.77* (2.56-5.57)
Allergy 14.0 (12.8-15.2) 1.04 (0.88-1.22)
Chronic or severe skin disease 3.0 (2.4-3.7) 1.26 (0.94-1.69)
§adjusted for age, gender and the other diseases, *significant (p < 0.05).
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Table 4 Cost ratios (CR) of health expenses by activity limitations and chronic conditions§, adjusted for age, gender,
education, income, nationality, household type and degree of urbanisation, in function of payment modalities
Total health
expenditure
Covered by
health insurance
Out-of-pocket Supplement
CR 95% CI CR 95% CI CR 95% CI CR 95% CI
Activity limitations adjusted for chronic conditions
No limitation 1.00 1.00 1.00 1.00
Moderate activity limitation 1.88 (1.59-2.22) 1.91 (1.62-2.56) 1.54 (1.35-1.76) 1.64 (1.33-2.03)
Severe activity limitation 3.21 (2.57-4.02) 3.41 (2.72-4.27) 2.03 (1.67-2.48) 2.14 (1.52-3.01)
Chronic condition adjusted for activity limitations
No chronic condition# 1.00 1.00 1.00 1.00
1 chronic condition# 1.82 (1.57-2.11) 1.81 (1.56-2.09) 1.76 (1.56-1.99) 1.26 (1.05-1.52)
≥2 chronic conditions# 2.84 (2.41-3.35) 2.87 (2.43-3.38) 2.51 (2.19-3.87) 1.51 (1.23-1.89)
Activity limitations and chronic conditions combined
No activity limitation - no chronic condition# 1.00 1.00 1.00 1.00
No activity limitation – 1 chronic condition# 1.94 (1.66-2.27) 1.93 (1.65-2.26) 1.86 (1.63-2.11) 1.27 (1.04-1.55)
No activity limitation – ≥2 chronic conditions# 3.01 (2.48-3.65) 3.04 (2.51-3.69) 2.59 (2.20-3.04) 1.33 (1.04-1.71)
Moderate activity limitation - no chronic condition# 2.46 (1.74-3.48) 2.50 (1.77-3.54) 1.82 (1.36-2.44) 1.46 (1.02-2.09)
Moderate activity limitation – 1 chronic condition# 3.16 (2.38-4.20) 3.21 (2.43-4.25) 2.59 (2.06-3.25) 2.06 (1.29-3.04)
Moderate activity limitation - ≥2 chronic conditions# 5.20 (4.23-6.39) 5.33 (4.34-6.55) 3.82 (3.26-4.48) 2.55 (1.87-3.48)
Severe activity limitation - no chronic condition# 4.45 (2.47-8.02) 4.70 (2.57-8.58) 2.82 (1.66-4.79) 1.21 (0.60-2.43)
Severe activity limitation – 1 chronic condition# 4.80 (2.99-7.70) 5.14 (3.20-8.25) 2.92 (1.92-4.45) 1.87 (1.00-3.51)
Severe activity limitation - ≥ 2 chronic conditions# 9.60 (7.41-12.44) 10.22 (7.87-13.27) 5.31 (4.24-6.64) 4.11 (2.68-6.29)
Activity limitations – stratified analysis
No chronic condition# No activity limitation 1.00 1.00 1.00 1.00
Moderate activity limitation 2.47 (1.73-3.52) 2.51 (1.77-3.58) 1.82 (1.36-2.45) 1.45 (1.01-2.07)
Severe activity limitation 4.21 (2.43-7.32) 4.46 (2.54-7.85) 2.66 (1.62-4.36) 1.16 (0.57-2.35)
1 chronic condition# No activity limitation 1.00 1.00 1.00 1.00
Moderate activity limitation 1.51 (1.14-2.00) 1.54 (1.17-2.04) 1.32 (1.05-1.66) 1.59 (1.07-2.34)
Severe activity limitation 2.42 (1.53-3.81) 2.60 (1.65-4.11) 1.57 (1.04-2.35) 1.50 (0.82-2.73)
≥ 2 chronic conditions# No activity limitation 1.00 1.00 1.00 1.00
Moderate activity limitation 1.72 (1.39-2.14) 1.75 (1.40-2.17) 1.49 (1.26-1.77) 1.90 (1.35-2.70)
Severe activity limitation 3.21 (2.49-4.14) 3.37 (2.60-4.36) 2.12 (1.70-2.65) 2.98 (1.91-4.63)
§Defined as: having suffered in the past 12 months from at least one of the following health problems: asthma, chronic bronchitis, myocardial infarction, coronary
heart disease, stroke, hypertension, osteoarthritis, neck disorder, depression, peptic ulcer, problem large bowel, diabetes, thyroid problems, kidney problems
except for kidney stones, cancer.
#Limited to list of chronic conditions specified above.
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than for health care expenditures covered by the health
insurance (47.7%) and out-of-pocket payments (52.3%).
Discussion
This study aimed to investigate the predictive value of
the GALI on health care expenditures in relation to the
presence of chronic conditions. Our findings indicate
that activity limitations, as measured by the GALI, are a
strong determinant of health care expenditures. To some
extent differences in health care expenditures by level of
activity limitations can be explained by chronic conditions.However, also after controlling for chronic conditions,
there is a strong and independent association between ac-
tivity limitations and health care expenditures.
From a conceptual point of view the GALI is a meas-
ure of participation (about functioning at the societal
level), rather than an indicator on functional limitations
(limitations with basic actions such walking, climbing
steps, reading, communication). It embodies the social
model of disability, which has also influenced the
current WHO classification (ICF) [43]. In this model the
availability of facilities aiming at a better participation of
people with functional limitations into society is an
Table 5 Decomposition of the gap between people with activity limitations (AL) and no activity limitations in terms of
the natural logarithm of the health care expenditure and the contribution of each variable in creating this gap in the
explained and unexplained components
Log (health care expenditure) Total health expenditure Covered by health insurance Out-of-pocket Supplement
Coeff. p-value Coeff. p-value Coeff. p-value Coeff. p-value
Prediction in people with AL 7.499 <0.001 7.319 <0.001 5.379 <0.001 2.245 <0.001
Prediction in people without AL 5.894 <0.001 5.662 <0.001 4.201 <0.001 1.395 <0.001
Gap 1.605 <0.001 1.657 <0.001 1.178 <0.001 0.850 <0.001
Explained (prevalence)
Age 0.324 <0.001 0.333 <0.001 0.279 <0.001 0.143 <0.001
Gender 0.056 <0.001 0.053 <0.001 0.053 <0.001 0.037 <0.001
Education 0.049 0.030 0.054 0.015 0.026 0.175 −0.038 0.152
Income −0.010 0.564 −0.005 0.751 −0.038 0.011 −0.036 0.072
Nationality 0.018 0.099 0.016 0.110 0.015 0.042 0.004 0.783
Household type −0.025 0.265 −0.019 0.402 −0.044 0.017 0.007 0.889
Degree of urbanisation 0.002 0.706 0.001 0.749 0.002 0.549 0.001 0.256
Chronic condition 0.356 <0.001 0.356 <0.001 0.324 <0.001 0.141 <0.001
Total 0.768 <0.001 0.791 <0.001 0.616 <0.001 0.259 <0.001
Unexplained (impact)
Age 0.882 0.023 0.871 0.026 0.586 0.033 0.605 0.109
Gender −0.635 0.003 −0.616 0.004 −0.516 0.002 0.010 0.973
Education 0.347 0.029 0.337 0.034 0.271 0.040 0.334 0.108
Income −0.118 0.394 −0.128 0.357 0.009 0.936 −0.007 0.966
Nationality −0.004 0.852 −0.005 0.837 0.002 0.907 0.018 0.570
Household type −0.284 0.035 −0.283 0.035 −0.090 0.386 −0.084 0.722
Degree of urbanisation −0.031 0.649 −0.029 0.669 −0.036 0.502 −0.032 0.304
Chronic condition −0.151 0.260 −0.149 0.271 −0.075 0.482 0.233 0.129
Constant 0.830 0.118 0.867 0.104 0.410 0.295 −0.486 0.385
Total 0.837 <0.001 0.866 <0.001 0.562 0.000 0.591 <0.001
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increasingly on this social model, it is important that
measures taking into account this component are used
in disability research.
The health care expenditures for which the research
questions were investigated include the majority of
health expenses. Fixed hospital costs, representing about
a fifth of the total expenditure, were not included. Infor-
mation was also available for out-of-pocket and supple-
mental payments. Due to the compulsory nature of the
Belgian health insurance and the representativeness of
the sample, extrapolation of the study results to the total
Belgian population is warranted.
The descriptive results clearly demonstrate the impact
of activity limitations on health care expenditure in ab-
solute terms. Although the context, the target group and
the concept of disability differ from a study conducted
in the US in 2007–2008 [27], it is remarkable that the
median overall health care expenditures earlier reportedare close to our findings (4234 US$ for persistent dis-
ability, 1612 US$ for temporary disability and 748 US$
for no disability). Another US study [26] also reports
values that are in line with the figures of our study.
Although the population with activity limitations rep-
resents only one fifth of the population, it accounts for
almost half of the health care expenditures. If a causal
relationship is assumed, a reduction of activity limitations
in the population could lead to considerable savings.
The mechanism through which activity limitations
lead to higher health care expenses cannot solely be ex-
plained in terms of differences in chronic conditions.
Most studies exploring differences in health care expen-
ditures focus either on disability, either on chronic con-
ditions [44]. However, the conceptual framework of
disability currently preferred by most experts is one in
which disability is related to, but separate from chronic
conditions [21]. There are several reasons for this. First,
the disabling impact of different chronic conditions
Van der Heyden et al. BMC Public Health  (2015) 15:267 Page 10 of 12varies [45]. Musculoskeletal diseases contribute a lot to
the burden of disability; for well treated hypertension
the disabling effect is negligible. Second, disentangling dis-
ability and chronic conditions helps to highlight the social
dimension of disability as an explanatory factor for differ-
ences in health care expenditures. Our results clearly indi-
cate that chronic conditions explain to a certain extent, but
definitely not completely, differences in health care expen-
ditures by level of activity limitation. Although the inde-
pendent association between activity limitations and health
care expenditures, observed in this study, may have been
partially due to chronic conditions which were neither in
the list, nor reported, the strength of the association sug-
gests that an important fraction of health care expenditures
is generated by health related activity limitations among
people with no chronic conditions. Maybe there is link with
acute health problems or disabilities since birth that are not
associated with chronic conditions. A better understanding
of the nature and causes of those activity limitations may
help health policy makers identify areas on which they
should focus to improve population health and reduce
health care expenditures. Third, health care expenditures
are also associated with chronic conditions without or with
only moderate activity limitations. Unfortunately our study
does not allow concluding that the health care provided to
those patients controls their chronic conditions to such an
extent that they are able to participate on an equal basis in
social roles and activities. Further research addressing this
issue would be very interesting.
The fraction of the population with zero health care
expenses was in our study minimal (only 5.7%) and the
log transformation of the health care expenses corrected
for the skewness of the distribution. Therefore the use of
linear regression was appropriate. A similar approach
has been used in other studies investigating the associ-
ation between disability and health care costs [23].
In our study we used the Blinder-Oaxaca decompos-
ition method to try to explain differences in health care
expenditures. Although multivariate regression models
are suitable to address differences in the importance of
individual predictors, decomposing techniques demon-
strate the relative importance of each predictor. The de-
composition illustrates the fraction of the gap in health
care expenditures that is attributable to group differ-
ences in the magnitudes of the determinants, which is
the prevalence effect, and to group differences in the ef-
fects of these determinants, which is the impact effect.
The Blinder-Oaxaca decomposition method is particu-
larly useful to study differences in health care expendi-
tures between two groups [38,39], but it has also been
used in studies in which the contribution of both the
prevalence and the impact of determinants to explain
differences between groups was investigated for other
health outcomes [40,41].The principal finding from the decomposition analysis
is that the gap in health care expenditures between
people with and without activity limitations is not sig-
nificantly affected by a different impact of chronic condi-
tions. This finding confirms that chronic conditions and
activity limitations are different concepts that need to be
disentangled.
The association between activity limitations and health
care expenditures is stronger for health care expenditures
covered by the health insurance than for out-of-pocket pay-
ments. As activity limitations can be considered a need fac-
tor, this finding reflects that there is a clearer link between
need and use of public health resources than between need
and own contributions. It supports the hypothesis that
strategies for the reimbursement of health care expendi-
tures in Belgium, aiming at an efficient and rational use of
public health funds, are quite successful.
Supplemental payments are not only related to health
needs, but also to extra patient comfort. Therefore it is
not surprising that a weaker association is found with
activity limitations than this is the case for the other
types of health care expenses. Probably this is also the
reason why the fraction of the gap in health care expen-
ditures by activity limitation that is explained by socio-
demographic characteristics and prevalence of chronic
conditions is smaller for supplemental payments than
for the other types of health care expenses.
To our knowledge this is the first published study to
investigate differences in health care expenditures by
disability status in a representative sample of a European
country. The Belgian health system is based on a Bis-
marckian model, which is essentially characterised by a
premium financed social insurance system with a mix-
ture of public and private providers. This is opposed to
the Beveridge model in the UK and the Scandinavian
countries, based on taxation with many public providers,
and the private insurance model of the US [46]. The ex-
tent to which the type of health system interferes with
the observed results is unknown. Probably the effect of
the health system is minor. Studies in the US including
disability measures that essentially measured functional
status report results that are quite comparable with
ours.
Our findings are also important from a health policy
perspective. In the planning of strategies for health care
cost containment, policymakers should not only con-
sider the impact of chronic diseases on health care ex-
penditures, but also be aware of the role of disability and
its consequences. Reducing activity limitations in the
population, e.g. by measures that facilitate the participa-
tion of people with functional limitations in the society,
is cost effective, not only because it increases the quality
of life and the productivity of people, but also because of
its direct impact on the health care costs.
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the initial study sample was representative of the total
population, some groups had to be excluded: people for
whom no linkage could be done (4.4%), people for
whom no self-administered questionnaire was available,
mostly because of a proxy interview (18.6%), people
who did not answer the GALI question (1.2%) and re-
spondents who died in the 12 months following partici-
pation in the survey (less than 0.5% of the total). Even
though it is known that health care expenditures in-
crease drastically during the last year of life [47], it is
assumed that the exclusion of the latter group did not
affect the results substantially, because of its small size.
In contrast, the exclusion of proxy interviews, in which
information on the GALI is lacking, may have had a
bigger impact on the results. Respondents interviewed
by proxy are probably in worse health, and therefore have
higher health care expenditures, than self-respondents.
Whereas this may have influenced the level of the health
care expenditures, it is not sure that this had an impact on
the associations that were investigated.
Some health care expenditures were not included, e.g.
fixed day fees for a hospital stay. The same applies for
health care expenditures that were not reported within
the compulsory health insurance system, although these
represent only a marginal fraction in comparison with
the reported health care expenditures.
Information on chronic conditions was based on self-
reports. The validity of self-reported specific chronic dis-
eases is limited and strongly depends on the type of disease
[48,49]. Furthermore chronic conditions included in the
study were restricted to the list of diseases available in the
Belgian HIS 2008.
Measuring disability is challenging. Although the
GALI has been validated, it remains a self-reported item,
with several crucial conceptual elements included in one
question. There may be concerns about the accuracy in
which respondents answer the question. However, the
results of this manuscript add evidence for the predictive
validity of the measure.
Conclusion
Activity limitations, both moderate and severe, are a
major driver for health care expenditures. This is
particularly the case for reimbursed health care ex-
penditures. Chronic conditions explain to a certain
extent differences in health care expenditures by
level of activity limitation. However, also in the ab-
sence of chronic conditions, activity limitations ap-
pear to be an important determinant of health care
expenditures. To make projections on health care
expenditures, routine data on activity limitations are
essential and complementary to data on chronic
conditions.Additional file
Additional file 1: The Blinder-Oaxaca decomposition method.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JVDH, HVO and NB conceived the study. JVDH performed the analyses and
wrote the manuscript. All authors were involved in the research and analysis
plan, critically reviewed and improved the manuscript, and approved the
final version of the manuscript.
Acknowledgements
The authors would like to thank the National Institute for Health and
Disability Insurance Belgium for their support for the linkage of the data of
the Health Interview Survey with the health insurance data.
Funding
The organization of the Belgian National Health Interview Survey was funded
by the federal, regional and community health authorities in Belgium. The
linkage of the survey data with the health insurance data was funded by the
National Institute for Health and Disability Insurance Belgium.
Author details
1Department of Public Health and Surveillance, Scientific Institute of Public
Health, 14, Juliette Wytsmanstraat, 1050 Brussels, Belgium. 2Department of
Public Health, Ghent University, Ghent, Belgium. 3Faculty of Public Health &
Policy, London School of Hygiene & Tropical Medicine, London, UK.
Received: 8 October 2014 Accepted: 4 March 2015
References
1. Organisation for Economic Co-operation and Development. OECD.Stat
Extracts. https://stats.oecd.org/Index.aspx?DataSetCode=SHA. 2014.
2. McDermott S, Turk MA. The myth and reality of disability prevalence:
measuring disability for research and service. Disabil Health J. 2011;4:1–5.
3. Altman BM. Disability Definitions. Models: Classification Schemes, and
Applications. In Handbook of Disability Studies. Edited by Albrecht G,
Seelman K, Bury M. Sage Publications, Inc.; 2001.
4. Madans JH, Loeb ME, Altman BM. Measuring disability and monitoring the
UN Convention on the Rights of Persons with Disabilities: the work of the
Washington Group on Disability Statistics. BMC Public Health. 2011;11
Suppl 4:S4.
5. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW, Cleveland MA.
Studies of illness in the aged. The index of ADL: a standardized measure of
biological and psychological function. JAMA. 1963;185:914–9.
6. Lawton MP, Brody EM. Assessment of older people: self-maintaining and
instrumental activities of daily living. Gerontologist. 1969;9:179–86.
7. Leonardi M, Bickenbach J, Ustun TB, Kostanjsek N, Chatterji S. The definition
of disability: what is in a name? Lancet. 2006;368:1219–21.
8. Palmer M, Harley D. Models and measurement in disability: an international
review. Health Policy Plan. 2012;27:357–64.
9. Verbrugge L. A global disability indicator. J Aging Stud. 1997;11:337–62.
10. Robine JM, Jagger C, Egidi V, Gispert M, Nusselder W, Perenboom R.
Creating a coherent set of indicators to monitor health across Europe: the
Euro-REVES 2 project. Eur J Publ Health. 2003;13:6–14.
11. Robine JM, Cambois E, Nusselder W, Jeune B, Oyen HV, Jagger C. The joint
action on healthy life years (JA: EHLEIS). Arch Public Health. 2013;71:2.
12. Lagiewka K. European innovation partnership on active and healthy ageing:
triggers of setting the headline target of 2 additional healthy life years at
birth at EU average by 2020. Arch Public Health. 2012;70:23.
13. Cox B, Van Oyen H, Cambois E, Jagger C, Le Roy S, Robine JM, et al. The
reliability of the Minimum European Health Module. Int J Public Health.
2009;54:55–60.
14. Van Oyen H, Van der Heyden J, Perenboom R, Jagger C. Monitoring
population disability: evaluation of a new Global Activity Limitation
Indicator (GALI). Soz Praventivmed. 2006;51:153–61.
Van der Heyden et al. BMC Public Health  (2015) 15:267 Page 12 of 1215. Cabrero-Garcia J, Julia-Sanchis R. The Global Activity Limitation Index mainly
measured functional disability, whereas self-rated health measured physical
morbidity. J Clin Epidemiol. 2014;67:468–76.
16. Romero-Ortuno R, Fouweather T, Jagger C. Cross-national disparities in sex
differences in life expectancy with and without frailty. Age Ageing.
2014;43:222–8.
17. Verropoulou G. Specific versus general self-reported health indicators
predicting mortality among older adults in Europe: disparities by gender
employing SHARE longitudinal data. Int J Public Health. 2014;59:665–78.
18. EHLEIS Team. GALI validation using the European Health Interview Survey.
Technical report_2013_7.1. 2013.
19. EHLEIS Team. GALI validation studies in Belgium. Technical_report_2014_7.1.
2014.
20. Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK. Defining and
measuring chronic conditions: imperatives for research, policy, program,
and practice. Prev Chronic Dis. 2013;10:E66.
21. Reichard A, Nary D, Simpson J. Research contributions and implications.
Disabil Health J. 2014;7:6–12.
22. Drum CE. The dynamics of disability and chronic conditions. Disabil Health
J. 2014;7:2–5.
23. Chan L, Beaver S, MacLehose RF, Jha A, Maciejewski M, Doctor JN. Disability
and health care costs in the Medicare population. Arch Phys Med Rehabil.
2002;83:1196–201.
24. Fried TR, Bradley EH, Williams CS, Tinetti ME. Functional disability and health
care expenditures for older persons. Arch Intern Med. 2001;161:2602–7.
25. Liu K, Wall S, Wissoker D. Disability and Medicare costs of elderly persons.
Milbank Q. 1997;75:461–93.
26. Mitra S, Findley PA, Sambamoorthi U. Health care expenditures of living
with a disability: total expenditures, out-of-pocket expenses, and burden,
1996 to 2004. Arch Phys Med Rehabil. 2009;90:1532–40.
27. Pumkam C, Probst JC, Bennett KJ, Hardin J, Xirasagar S. Health care
expenditures among working-age adults with physical disabilities: variations
by disability spans. Disabil Health J. 2013;6:287–96.
28. Gerkens S, Merkur S. Belgium: health system review. Health Systems in
Transition. 2010;12:1–266.
29. Demarest S, Van der Heyden J, Charafeddine R, Drieskens S, Gisle L,
Tafforeau J. Methodological basics and evolution of the Belgian health
interview survey 1997–2008. Arch Public Health. 2013;71:24.
30. Kunst AE, Mackenbach JP. Measuring socio-economic inequalities in health.
EUR/ICP/RPD 416. Copenhagen: WHO Regional Office for Europe; 1994.
31. Mérenne B, Van Der Haegen H, Van Hecke E. La Belgique, diversité
territoriale. Bruxelles: Service Publications du Crédit Communal; 1997.
32. Van Hecke E, Halleux JM, Decroly JM, Mérenne-Schoumaker B. Sociaal-economische
Enquête 2001. Monografieën. Woonkernen en Stadsgewesten in een Verstedelijkt
België. Brussel: FOD Economie, KMO, Middenstand en Energie. Algemene Directie
Statistiek en Economische Informatie; 2009.
33. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing health
care utilization and costs. Annu Rev Public Health. 1999;20:125–44.
34. Dodd S, Bassi A, Bodger K, Williamson P. A comparison of multivariable
regression models to analyse cost data. J Eval Clin Pract. 2006;12:76–86.
35. Blinder AS. Wage Discrimination: Reduced Form and Structural Estimates.
J Hum Resour. 1973;8:436–55.
36. Jann B. The Blinder-Oaxaca decomposition for linear regression models.
Stata J. 2008;8:453–79.
37. Oaxaca R. Male–female Wage Differentials in Urban Labor Markets. Int Econ
Rev. 1973;14:693–709.
38. Ajmera M, Raval AD, Shen C, Sambamoorthi U. Explaining the increased
health care expenditures associated with gastroesophageal reflux disease
among elderly Medicare beneficiaries with chronic obstructive pulmonary
disease: a cost-decomposition analysis. Int J Chron Obstruct Pulmon Dis.
2014;9:339–48.
39. Chen J, Rizzo J. Racial and ethnic disparities in use of psychotherapy:
evidence from U.S. national survey data. Psychiatr Serv. 2010;61:364–72.
40. Emamian MH, Zeraati H, Majdzadeh R, Shariati M, Hashemi H, Fotouhi A.
The gap of visual impairment between economic groups in Shahroud, Iran:
a Blinder-Oaxaca decomposition. Am J Epidemiol. 2011;173:1463–7.
41. Ladin K. Decomposing differences in utilization of health services between
depressed and non-depressed elders in Europe. Eur J Ageing.
2012;9:51–64.
42. StataCorp. Stata Statistical Software: Release 13. College Station, TX:
StataCorp LP; 2013.43. WHO. International Classification of Functioning, Disability and Health.
Geneva: World Health Organization; 2001.
44. Hwang W, Weller W, Ireys H, Anderson G. Out-of-pocket medical spending
for care of chronic conditions. Health Aff (Millwood ). 2001;20:267–78.
45. Klijs B, Nusselder WJ, Looman CW, Mackenbach JP. Contribution of chronic
disease to the burden of disability. PLoS One. 2011;6:e25325.
46. Lameire N, Joffe P, Wiedemann M. Healthcare systems–an international
review: an overview. Nephrol Dial Transplant. 1999;14 Suppl 6:3–9.
47. Polder JJ, Barendregt JJ, Van Oers H. Health care costs in the last year of
life–the Dutch experience. Soc Sci Med. 2006;63:1720–31.
48. Martin LM, Leff M, Calonge N, Garrett C, Nelson DE. Validation of self-reported
chronic conditions and health services in a managed care population. Am
J Prev Med. 2000;18:215–8.
49. Van der Heyden J, De Backer D, Tafforeau J, Van Herck K. Reliability and
validity of a global question on self-reported chronic morbidity. J Public
Health (Springer). 2014;22:371–80.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
